U.S. Bioscience, Inc.
Records under this name other than patents U.S. Bioscience, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 6,239,119 | Topical administration of amifostine and related compounds Formerly held Term ended Term ended Apr 26, 2019 · From the USPTO record | Term ended | Term ended Apr 26, 2019 | From the USPTO record |
| US 6,384,259 | Stable amorphous amifostine compositions and dosage form Formerly held Term ended Ended no later than Nov 16, 2018 · From the USPTO record | Term ended | Ended no later than Nov 16, 2018 | From the USPTO record |
| US 6,407,278 | Stable amorphous amifostine compositions and methods for the preparation and use of the same Formerly held Term ended Ended no later than Nov 16, 2018 · From the USPTO record | Term ended | Ended no later than Nov 16, 2018 | From the USPTO record |
| US 6,017,922 | Thermally stable trimetrexates and processes for producing the same Formerly held Term ended Term ended May 18, 2018 · From the USPTO record | Term ended | Term ended May 18, 2018 | From the USPTO record |
| US 6,127,351 | Method for the administration of amifostine and related compounds Formerly held Term ended Term ended Feb 10, 2018 · From the USPTO record | Term ended | Term ended Feb 10, 2018 | From the USPTO record |
| US 6,017,921 | Crystalline trimetrexate salts and the process for making the same Formerly held Term ended Term ended Feb 4, 2018 · From the USPTO record | Term ended | Term ended Feb 4, 2018 | From the USPTO record |
| US 6,586,476 | Methods for the treatment of nephro-disorders using aminothiol compounds Formerly held Term ended Term ended Dec 9, 2017 · From the USPTO record | Term ended | Term ended Dec 9, 2017 | From the USPTO record |
| US 6,051,563 | Methods for the administration of amifostine and related compounds Formerly held Term ended Term ended Feb 12, 2017 · From the USPTO record | Term ended | Term ended Feb 12, 2017 | From the USPTO record |
| US 6,489,312 | Pharmaceutical formulations comprising aminoalkyl phosphorothioates Formerly held Lapsed on the fee record Ended Dec 3, 2010 · From the USPTO record | Lapsed on the fee record | Ended Dec 3, 2010 | From the USPTO record |
| US 6,258,821 | Compositions comprising trimetrexate and methods of their synthesis and use Formerly held Lapsed on the fee record Ended Jul 10, 2009 · From the USPTO record | Lapsed on the fee record | Ended Jul 10, 2009 | From the USPTO record |